The Valley Spectrum
  • Login
  • Top Stories
  • J&K
  • National
  • International
  • Business
  • Editorial
  • Health
  • Sports
  • More
    • Entertainment
    • Technology
No Result
View All Result
  • Top Stories
  • J&K
  • National
  • International
  • Business
  • Editorial
  • Health
  • Sports
  • More
    • Entertainment
    • Technology
No Result
View All Result
The Valley Spectrum
No Result
View All Result

Two New Medicines For Covid Treatment Get WHO Approval

by VS Desk
January 16, 2022
in International
0
Two New Medicines For Covid Treatment Get WHO Approval
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Eli Lilly & Co.’s rheumatoid arthritis drug and GlaxoSmithKline Plc’s monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe. 

There’s evidence that Lilly’s baricitinib can improve survival rates and reduce the need for ventilation in severely ill patients, the WHO said in a statement, advising a combination with corticosteroids. Two other drugs in the same class, known as JAK inhibitors, shouldn’t be used for Covid, the agency said.

The WHO’s guideline update validates conclusions reached months ago by some health regulators. The advice on baricitinib, for example, comes after U.S. and European Union agencies gave the drug emergency-use approval last May. Some scientists criticized the Geneva-based agency for not weighing in on antiviral pills developed by Pfizer Inc. and Merck & Co. in a timely manner. 

“The main issue with this version of the guideline is its silence concerning the potential community use of oral antiviral medications, which are now approved for use in multiple countries,” Penny Ward, a visiting professor in pharmaceutical medicine at King’s College London, said in remarks to the U.K.’s Science Media Center.  

The WHO also endorsed Glaxo and Vir Biotechnology Inc.’s monoclonal antibody for patients who aren’t very ill but are deemed likely to require hospitalization, even as it acknowledged the antibodies’ effectiveness against the omicron variant “is still uncertain.” The U.S. and the U.K. approved the Glaxo-Vir treatment last year.

Another monoclonal antibody developed by Regeneron Pharmaceuticals Inc. got the WHO’s endorsement last year. There isn’t enough data to recommend one product over the other, the Geneva-based agency said Friday.

Doctors Without Borders called on governments to ensure that the Lilly drug can be made available at low costs in poorer nations, saying generic forms are already sold in India and Bangladesh. 

Baricitinib has similar effects to other arthritis drugs called interleukin-6 inhibitors such as Roche Holding AG’s tocilizumab, so when both are available the WHO suggested choosing one based on cost, availability, and clinician experience. 

VS Desk

VS Desk

Next Post
Hong Kong Bans Transit Flights From 153 Countries Over Covid Concerns

Hong Kong Bans Transit Flights From 153 Countries Over Covid Concerns

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

England limps to 17-2 after Australia declares at 473-9

England limps to 17-2 after Australia declares at 473-9

1 year ago
US Offers $10 Million Reward In Hunt For Russia-Linked Cybercrime Group

US Offers $10 Million Reward In Hunt For Russia-Linked Cybercrime Group

2 years ago

Popular News

Plugin Install : Popular Post Widget need JNews - View Counter to be installed

Connect with us

  • About
  • Advertise
  • Careers
  • Contact
Call us: +1 234 JEG THEME

Copyright © 2021 The Valley Spectrum. The Valley Spectrum not responsible for the content of external sites.

No Result
View All Result
  • Top Stories
  • J&K
  • National
  • International
  • Business
  • Editorial
  • Health
  • Sports
  • More
    • Entertainment
    • Technology

Copyright © 2021 The Valley Spectrum. The Valley Spectrum not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In